All Stories

  1. HDAC8 regulates canonical Wnt pathway to promote differentiation in skeletal muscles
  2. Reversible immortalisation enables genetic correction of human muscle progenitors and engineering of next‐generation human artificial chromosomes for Duchenne muscular dystrophy
  3. Transient transcription factor (OSKM) expression is key towards clinical translation of in vivo cell reprogramming
  4. Intra‐arterial transplantation of HLA‐matched donor mesoangioblasts in Duchenne muscular dystrophy
  5. Intra-arterial transplantation of HLA-matched donor mesoangioblasts in Duchenne muscular dystrophy
  6. Out of the niche: exploring unknown pathways
  7. Inflammation Converts Human Mesoangioblasts Into Targets of Alloreactive Immune Responses: Implications for Allogeneic Cell Therapy of DMD
  8. Clinical Development of Gene Therapy Needs a Tailored Approach: A Regulatory Perspective from the European Union
  9. O03 Cell therapy for muscular dystrophies
  10. Clinical development of Gene therapy needs a tailored approach: A regulatory perspective from the EU
  11. Disruptive influence
  12. Targeting endothelial junctional adhesion molecule-A/ EPAC/ Rap-1 axis as a novel strategy to increase stem cell engraftment in dystrophic muscles
  13. Regulatory evaluation of Glybera in Europe — two committees, one mission
  14. Hemogenic endothelium generates mesoangioblasts that contribute to several mesodermal lineages in vivo
  15. Collagen VI regulates satellite cell self-renewal and muscle regeneration
  16. The Committee for Advanced Therapies' of the European Medicines Agency Reflection Paper on Management of Clinical Risks Deriving from Insertional Mutagenesis
  17. Dll4 and PDGF-BB Convert Committed Skeletal Myoblasts to Pericytes without Erasing Their Myogenic Memory
  18. Mesoangioblasts Suppress T Cell Proliferation Through IDO and PGE-2-Dependent Pathways
  19. Correction: Corrigendum: Mesoangioblast stem cells ameliorate muscle function in dystrophic dogs
  20. Human iPSC-derived mesoangioblasts, like their tissue-derived counterparts, suppress T cell proliferation through IDO- and PGE-2-dependent pathways
  21. Stem Cells for the Treatment of Muscular Dystrophy
  22. Injectable polyethylene glycol-fibrinogen hydrogel adjuvant improves survival and differentiation of transplanted mesoangioblasts in acute and chronic skeletal-muscle degeneration
  23. The increase of pericyte population in human neuromuscular disorders supports their role in muscle regeneration in vivo
  24. Stem cell therapies for muscle disorders
  25. Reprogramming of Pericyte-Derived Cells of the Adult Human Brain into Induced Neuronal Cells
  26. Quantitative muscle strength assessment in duchenne muscular dystrophy: longitudinal study and correlation with functional measures
  27. Hmgb3 Is Regulated by MicroRNA-206 during Muscle Regeneration
  28. Bystander Effect on Brain Tissue of Mesoangioblasts Producing Neurotrophins
  29. Noggin recruits mesoderm progenitors from the dorsal aorta to a skeletal myogenic fate
  30. ‘Hearts and bones’: the ups and downs of ‘plasticity’ in stem cell biology
  31. Sphingosine 1-Phosphate Induces Differentiation of Mesoangioblasts towards Smooth Muscle. A Role for GATA6
  32. Intrinsic cell memory reinforces myogenic commitment of pericyte‐derived iPSCs
  33. An evolutionarily acquired genotoxic response discriminates MyoD from Myf5, and differentially regulates hypaxial and epaxial myogenesis
  34. Towards a Cell Therapy for Muscular Dystrophy: Technical and Ethical Issues
  35. Mesoangioblasts from ventricular vessels can differentiate in vitro into cardiac myocytes with sinoatrial-like properties
  36. Repairing skeletal muscle: regenerative potential of skeletal muscle stem cells
  37. 19-P004 Endothelial derived myogenesis: Lineage tracing and contribution to muscle regeneration
  38. Hsp70 is required for optimal cell proliferation in mouse A6 mesoangioblast stem cells
  39. Challenges in translational research
  40. TGFβ protects mesoangioblasts from apoptosis via sphingosine kinase-1 regulation
  41. A highly Stable and Nonintegrated Human Artificial Chromosome (HAC) Containing the 2.4 Mb Entire Human Dystrophin Gene
  42. Stem Cells for the Treatment of Muscular Dystrophy
  43. Skeletal Muscle Differentiation of Embryonic Mesoangioblasts Requires Pax3 Activity
  44. New ISSCR Guidelines Underscore Major Principles for Responsible Translational Stem Cell Research
  45. Magic-Factor 1, a Partial Agonist of Met, Induces Muscle Hypertrophy by Protecting Myogenic Progenitors from Apoptosis
  46. PlGF–MMP-9–expressing cells restore microcirculation and efficacy of cell therapy in aged dystrophic muscle
  47. S5/2 Regulation of mitochondrial dynamics by nitric oxide is a key event in myogenesis
  48. Binding of sFRP-3 to EGF in the Extra-Cellular Space Affects Proliferation, Differentiation and Morphogenetic Events Regulated by the Two Molecules
  49. Correlation of Circulating CD133+ Progenitor Subclasses with a Mild Phenotype in Duchenne Muscular Dystrophy Patients
  50. O15. Nitric oxide, mitochondria and their dynamics in myogenesis
  51. Sampaolesi et al. reply
  52. Isolation and Characterization of Mesoangioblasts from Mouse, Dog, and Human Tissues
  53. New therapies for Duchenne muscular dystrophy: challenges, prospects and clinical trials
  54. Isolation and Characterization of Mesoangioblasts from Facioscapulohumeral Muscular Dystrophy Muscle Biopsies
  55. Cellular heterogeneity during vertebrate skeletal muscle development
  56. Sphingosine 1‐Phosphate Mediates Proliferation and Survival of Mesoangioblasts
  57. Oriented Cell Divisions and Muscle Satellite Cell Heterogeneity
  58. Stem and Progenitor Cells in Skeletal Muscle Development, Maintenance, and Therapy
  59. Beta catenin-independent activation of MyoD in presomitic mesoderm requires PKC and depends on Pax3 transcriptional activity
  60. Intrinsic phenotypic diversity of embryonic and fetal myoblasts is revealed by genome-wide gene expression analysis on purified cells
  61. Pericytes of human skeletal muscle are myogenic precursors distinct from satellite cells
  62. Allogeneic mesoangioblasts give rise to alpha-sarcoglycan expressing fibers when transplanted into dystrophic mice
  63. Mesoangioblast stem cells ameliorate muscle function in dystrophic dogs
  64. Reversine-treated fibroblasts acquire myogenic competence in vitro and in regenerating skeletal muscle
  65. Embryonic Stem–Derived Versus Somatic Neural Stem Cells: A Comparative Analysis of Their Developmental Potential and Molecular Phenotype
  66. Erratum to “Satellite cells, myoblasts and other occasional myogenic progenitors: Possible origin, phenotypic features and role in muscle regeneration” by Giulio Cossu, Stefano Biressi [Semin. Cell Dev. Biol. 16 (4–5) (2005) 623–631]
  67. Electrospun degradable polyesterurethane membranes: potential scaffolds for skeletal muscle tissue engineering
  68. Satellite cells, myoblasts and other occasional myogenic progenitors: Possible origin, phenotypic features and role in muscle regeneration
  69. Regulation of vertebrate myotome development by the p38 MAP kinase–MEF2 signaling pathway
  70. A Role for Msx2 and Necdin in Smooth Muscle Differentiation of Mesoangioblasts and Other Mesoderm Progenitor Cells
  71. Fusion of bone marrow–derived stem cells with striated muscle may not be sufficient to activate muscle genes
  72. New therapies for muscular dystrophy: cautious optimism
  73. Mouse orthologue of ARX, a gene mutated in several X‐linked forms of mental retardation and epilepsy, is a marker of adult neural stem cells and forebrain GABAergic neurons
  74. Human circulating AC133+ stem cells restore dystrophin expression and ameliorate function in dystrophic skeletal muscle
  75. Bsx, an evolutionary conserved Brain Specific homeoboX gene expressed in the septum, epiphysis, mammillary bodies and arcuate nucleus
  76. Stem Cells for the Treatment of Muscular Dystrophy: More Than Wishful Thinking?
  77. Bhlhb5 is expressed in the CNS and sensory organs during mouse embryonic development
  78. Skeletal myogenic progenitors in the endothelium of lung and yolk sac
  79. Mesoangioblasts — vascular progenitors for extravascular mesodermal tissues
  80. Neural Stem Cells: Plasticity and Their Transdifferentiation Potential
  81. Chapter 6 Somitic and non somitic progenitors of skeletal muscle
  82. Ontogeny of Skeletal Muscle Cells
  83. Prof Franco Tatò 1949–2001
  84. Back from the Tip of the Nose
  85. From developmental biology to dysmorphology
  86. Myogenic stem cells for the therapy of primary myopathies: wishful thinking or therapeutic perspective?
  87. Wnt signaling and the activation of myogenesis in mammals
  88. Differential expression of the Wnt putative receptors Frizzled during mouse somitogenesis
  89. Establishing myogenic identity during somitogenesis
  90. Redefining the Genetic Hierarchies Controlling Skeletal Myogenesis: Pax-3 and Myf-5 Act Upstream of MyoD
  91. Chapter 2 Myogenesis in the Mouse Embryo
  92. The Inhibition of Differentiation Caused by TGFβ in Fetal Myoblasts Is Dependent upon Selective Expression of PKCθ: A Possible Molecular Basis for Myoblast Diversification during Limb Histogenesis
  93. How is myogenesis initiated in the embryo?
  94. A Retroviral Vector Containing a Muscle-Specific Enhancer Drives Gene Expression Only in Differentiated Muscle Fibers
  95. Molecular biology and pathology of skeletal and cardiac myogenesis
  96. Induction of Calbindin-D28K by 1,25-dihydroxyvitamin D3 in cultured chicken intestinal cells
  97. The Effects of AZT and DDI on Pre- and Postimplantation Mammalian Embryos: An In Vivo and In Vitro Study
  98. Differential expression of muscle-specific enolase in embryonic and fetal myogenic cells during mouse development
  99. Differentiation-dependent expression of apolipoprotein A-I in chicken myogenic cells in culture
  100. Altered protein phosphorylation in murine muscular dystrophy
  101. Reduced acetylcholine-induced channel activity in dystrophic mouse myotubes
  102. Expression of adult fast pattern of acetylcholinesterase molecular forms by mouse satellite cells in culture
  103. Acetylcholine receptor channels are present in undifferentiated satellite cells but not in embryonic myoblasts in culture
  104. Chapter 9 Cell Heterogeneity in The Myogenic Lineage
  105. Alterations of lipid composition in a dystrophic muscle cell line
  106. A muscle cell line from dystrophic mice expressing an altered phenotype in vitro
  107. Neural control of early myogenic differentiation in cultures of mouse somites
  108. Altered distribution of protein kinase C in dystrophic muscle cells and its modulation by liposome-delivered phospholipids
  109. Emergence of TPA-resistant ‘satellite’ cells during muscle histogenesis of human limb
  110. Synthesis of glycoconjugates in mouse primordial germ cells
  111. Increased sialylation of complex glycopeptides during differentiation of mouse embryonal carcinoma cells
  112. Lactosaminoglycans synthesized by mouse male germ cells are fucosylated by an epididymal fucosyltransferase
  113. Reduced acetylcholine sensitivity in dystrophic mouse myotubes in vitro
  114. Differential response of satellite cells and embryonic myoblasts to a tumor promoter
  115. Isolation and chemical characterization of a melanoma-associated proteoglycan antigen
  116. Development of ‘revertant’ myotubes in cultures of Rous sarcoma virus transformed avian myogenic cells
  117. Covalent binding of lactosaminoglycans and heparan sulphate to fibronectin synthesized by a human teratocarcinoma cell line
  118. Altered Glycoprotein Carbohydrates in Malignant Cells
  119. THE BOUND CARBOHYDRATES OF GLYCOPROTEINS IN NORMAL AND PATHOLOGICAL STATES*
  120. TPA-Induced Inhibition of the Expression of Differentiative Traits in Cultured Myotubes: Dependence on Protein Synthesis
  121. Glycopeptide alterations induced by 12-O-tetradecanoyl phorbol-13-acetate in chick embryo cultured myotubes
  122. Vitamin A inhibits chondrogenesis but not myogenesis
  123. Appearance of a class of cell-surface fucosyl-glycopeptides in differentiated muscle cells in culture
  124. Differentiation in Culture of Myogenic Cells from Adult Mouse Muscle
  125. DNA replication during muscle cell differentiation: identification of multiple DNA-dependent DNA polymerases
  126. Non Muscle Stem Cells and Muscle Regeneration